AstraZeneca Pharma India share news, announcements and annual reports
NSE: ASTRAZENBSE: 506820Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 30 Oct 2026. Previous close ₹6,299.00.
30 Oct: open ₹6,300.00, high ₹6,380.00, low ₹6,240.50
- Next results date: the board meets on 5 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹15,911 Cr333rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 93.81
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 18.23
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.57%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 20.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 24.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 6,84556.8% delivered
AstraZeneca Pharma India has 671 announcements on record, routine notices left out; 4 in the 30 days to 1 Nov 2026, the latest on 30 Oct 2026.
Next board meeting and results date
As the company gave notice to the exchange.AstraZeneca Pharma India quarterly results
The board meets on 5 Nov 2026 to consider financial results
Notice filed 30 Oct 2026
To consider and approve the financial results for the period ended September 30, 2026
AstraZeneca Pharma India annual reports, presentations and earnings calls
The company's own documents, latest first.AstraZeneca Pharma India financials, year by year
Annual reports17
- Annual report, year to Mar 202618 Jul 2026
- Annual report, year to Mar 202522 Jul 2025
- Annual report, year to Mar 202416 Jul 2024
- Annual report, year to Mar 202322 Jul 2023, a zip file
- Annual report, year to Mar 202215 Jul 2022, a zip file
12 earlier reports
- Annual report, year to Mar 202116 Jul 2021, a zip file
- Annual report, year to Mar 202017 Jul 2020, a zip file
- Annual report, year to Mar 201911 Jul 2019, a zip file
- Annual report, year to Mar 201812 Sep 2018, a zip file
- Annual report, year to Mar 201715 Sep 2017, a zip file
- Annual report, year to Mar 201626 Aug 2016, a zip file
- Annual report, year to Mar 201518 Aug 2015, a zip file
- Annual report, year to Mar 20149 Sep 2014, a zip file
- Annual report, year to Mar 201330 Jul 2013, a zip file
- Annual report, year to Mar 201227 Jun 2012, a zip file
- Annual report, year to Mar 201116 Dec 2011, a zip file
- Annual report, year to Mar 20107 Apr 2011, a zip file
AstraZeneca Pharma India share news and announcements
Newest first. Page 1 of 14.
Oct 2026
30 Oct · Board meeting
16 Oct · Rating
Sep 2026
18 Sep · Legal
15 Sep · Management
15 Sep
2 Sep
Aug 2026
25 Aug · Legal
24 Aug
21 Aug · Analysts
15 Aug · Analysts
11 Aug · Business
10 Aug · Meeting
10 Aug · Results
8 Aug
4 Aug · Board meeting
Jul 2026
30 Jul · Legal
28 Jul · Legal
28 Jul
22 Jul · Updates
22 Jul · Management
21 Jul
18 Jul · Corporate action
18 Jul · Meeting
16 Jul
6 Jul
Jun 2026
16 Jun
13 Jun · Management
12 Jun
11 Jun
1 Jun
May 2026
26 May · Results
21 May
20 May
12 May · Amendment to AOA/MOA
12 May · Amendment to AOA/MOA
Apr 2026
10 Apr
10 Apr · Meeting
Mar 2026
31 Mar
20 Mar
How the price met the news
The latest 30. The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.Delivery against usualDelivery against usual. The share of the session's volume delivered into demat accounts, rather than bought and sold again the same day, less its average over the twenty sessions before, in percentage points (pts). Delivery against usual in the glossary
- 16 Oct 2026Credit ratingup 0.56%+0.2 pts vs Nifty 500market median 0.0% · five sessions +0.9% (+4.3 pts vs Nifty 500) · volume 0.9× usual · delivery +6.4 pts against usual · The announcement
- 16 Sep 2026Board or managers changedup 0.11%−0.1 pts vs Nifty 500market median 0.0% · five sessions +0.2% (−1.2 pts vs Nifty 500) · volume 1.4× usual · delivery −4.2 pts against usual · The announcement
- 22 Jul 2026Board or managers changeddown 0.71%+0.2 pts vs Nifty 500market median 0.0% · five sessions −0.2% (+0.8 pts vs Nifty 500) · volume 0.4× usual · delivery −1.4 pts against usual · The announcement
- 15 Jun 2026Board or managers changedup 2.11%+0.8 pts vs Nifty 500market median 0.0% · five sessions +2.2% (−0.2 pts vs Nifty 500) · volume 0.6× usual · delivery −3.4 pts against usual · The announcement
- 27 May 2026Resultsdown 3.51%−3.8 pts vs Nifty 500market median −0.7% · five sessions −4.5% (−2.6 pts vs Nifty 500) · volume 11.6× usual · delivery −2.5 pts against usual · The announcement
- 12 Feb 2026Resultsdown 2.69%−2.1 pts vs Nifty 500market median −0.7% · five sessions −2.0% (−1.4 pts vs Nifty 500) · volume 4.5× usual · delivery −26.9 pts against usual · The announcement
- 10 Nov 2025Resultsup 0.06%−0.3 pts vs Nifty 500market median −0.7% · five sessions +0.8% (−0.5 pts vs Nifty 500) · volume 2.8× usual · delivery −12.7 pts against usual · The announcement
- 2 Sep 2025Credit ratingup 1.85%+1.8 pts vs Nifty 500market median 0.0% · five sessions +3.2% (+2.5 pts vs Nifty 500) · volume 0.8× usual · delivery +3.0 pts against usual · The announcement
- 14 Aug 2025Resultsdown 1.21%−1.1 pts vs Nifty 500market median −0.7% · five sessions −0.3% (−2.2 pts vs Nifty 500) · volume 13.3× usual · delivery +0.1 pts against usual · The announcement
- 10 Jun 2025Board or managers changeddown 0.02%−0.1 pts vs Nifty 500market median 0.0% · five sessions +2.1% (+3.1 pts vs Nifty 500) · volume 0.4× usual · delivery −23.7 pts against usual · The announcement
20 earlier announcements
- 2 Jun 2025Dividendup 17.12%+17.0 pts vs Nifty 500market median 0.0% · five sessions +22.8% (+21.2 pts vs Nifty 500) · volume 98.2× usual · delivery −39.8 pts against usual · The announcement
- 2 Jun 2025Resultsup 17.12%+17.0 pts vs Nifty 500market median −0.7% · five sessions +22.8% (+21.2 pts vs Nifty 500) · volume 98.2× usual · delivery −39.8 pts against usual · The announcement
- 12 Feb 2025Resultsup 0.68%+0.9 pts vs Nifty 500market median −0.7% · five sessions −6.3% (−4.7 pts vs Nifty 500) · volume 3.9× usual · delivery −13.7 pts against usual · The announcement
- 28 May 2024Dividendup 0.47%+1.0 pts vs Nifty 500market median 0.0% · five sessions −5.7% (−7.1 pts vs Nifty 500) · volume 3.7× usual · delivery −29.7 pts against usual · The announcement
- 28 May 2024Board or managers changedup 0.47%+1.0 pts vs Nifty 500market median 0.0% · five sessions −5.7% (−7.1 pts vs Nifty 500) · volume 3.7× usual · delivery −29.7 pts against usual · The announcement
- 9 Feb 2024Resultsdown 12.90%−12.8 pts vs Nifty 500market median −0.7% · five sessions −16.1% (−16.4 pts vs Nifty 500) · volume 12.3× usual · delivery +3.6 pts against usual · The announcement
- 10 Nov 2023Resultsdown 5.29%−5.5 pts vs Nifty 500market median −0.7% · five sessions −5.2% (−7.4 pts vs Nifty 500) · volume 6.3× usual · delivery −23.1 pts against usual · The announcement
- 14 Aug 2023Resultsup 1.81%+2.0 pts vs Nifty 500market median −0.7% · five sessions +7.0% (+7.1 pts vs Nifty 500) · volume 20.9× usual · delivery −38.2 pts against usual · The announcement
- 1 Aug 2023Board or managers changeddown 0.96%−0.9 pts vs Nifty 500market median 0.0% · five sessions −1.4% (−0.8 pts vs Nifty 500) · volume 0.6× usual · delivery +6.2 pts against usual · The announcement
- 31 May 2023Dividendup 6.54%+6.7 pts vs Nifty 500market median 0.0% · five sessions +4.3% (+3.8 pts vs Nifty 500) · volume 21.7× usual · delivery −34.6 pts against usual · The announcement
- 13 Feb 2023Resultsdown 1.93%−1.2 pts vs Nifty 500market median −0.7% · five sessions −0.5% (−0.4 pts vs Nifty 500) · volume 1.7× usual · delivery −8.3 pts against usual · The announcement
- 15 Dec 2022Board or managers changeddown 0.36%+0.8 pts vs Nifty 500market median 0.0% · five sessions +2.5% (+5.3 pts vs Nifty 500) · volume 0.6× usual · delivery −10.2 pts against usual · The announcement
- 14 Nov 2022Resultsdown 3.10%−3.1 pts vs Nifty 500market median −0.7% · five sessions −4.7% (−4.1 pts vs Nifty 500) · volume 2.6× usual · delivery +2.3 pts against usual · The announcement
- 10 Aug 2022Board or managers changeddown 0.48%−0.4 pts vs Nifty 500market median 0.0% · five sessions −2.6% (−5.2 pts vs Nifty 500) · volume 0.6× usual · delivery −16.1 pts against usual · The announcement
- 30 May 2022Dividenddown 1.08%−3.1 pts vs Nifty 500market median 0.0% · five sessions −0.1% (−1.6 pts vs Nifty 500) · volume 2.3× usual · delivery −32.0 pts against usual · The announcement
- 10 Aug 2021Dividenddown 2.75%−2.4 pts vs Nifty 500market median 0.0% · five sessions −5.6% (−6.6 pts vs Nifty 500) · volume 1.3× usual · delivery −13.2 pts against usual · The announcement
- 26 May 2021Resultsup 0.88%+0.4 pts vs Nifty 500market median −0.7% · five sessions −2.6% (−4.5 pts vs Nifty 500) · volume 1.3× usual · delivery −14.1 pts against usual · The announcement
- 8 Sep 2020Dividenddown 7.07%−6.5 pts vs Nifty 500market median 0.0% · five sessions −5.5% (−6.7 pts vs Nifty 500) · volume 14.0× usual · delivery −24.9 pts against usual · The announcement
- 11 Aug 2020Dividenddown 1.37%−1.6 pts vs Nifty 500market median 0.0% · five sessions −1.3% (−1.3 pts vs Nifty 500) · volume 0.6× usual · delivery +1.6 pts against usual · The announcement
- 8 Aug 2019Dividenddown 2.44%−3.8 pts vs Nifty 500market median 0.0% · five sessions −12.7% (−14.2 pts vs Nifty 500) · volume 2.3× usual · delivery +16.2 pts against usual · The announcement
AstraZeneca Pharma India results filing dates and deadlines
Listed companies must file quarterly results within 45 days, and the year's within 60.
Days to fileDays to file. The days from the period's end to the day the results reached the exchange.DeadlineDeadline, days. The days the rules allow from the period's end: 45 for a quarter or half year, and 60 for the year and the March quarter filed with it. A company that listed after the period ended has until 21 days after its listing where that is later.